Temple University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Temple University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Temple University: 163 sponsored US clinical trials, 21 recruiting.
Temple University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 128 completed. 18 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Temple University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
128 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 1 of 4
Photo-experiencing and Reflective Listening (PEARL) to Promote Healing Engagement for Survivors of Violence
NCT07277816
Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
NCT07151768
Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
NCT07027865
Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care
NCT06810557
Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)
NCT06530693
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
NCT06804109
Temple Health Chest Initiative (THCI 2.0)
NCT06933758
Oropharyngeal Candidiasis (OPC) and S-ECC
NCT05761197
Need to be Needed (N2BN) Intervention
NCT06510439
Peer Facilitated Waitlist Controlled Transportation Study
NCT06370767
Taking Action for College Students
NCT06700902
RemI for Post-Bariatric Surgery Weight Regain
NCT06292936
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
NCT06336616
Creating Welcoming Faith Communities for People With Serious Mental Illnesses
NCT06336980
Biological Effects of Quercetin in COPD Phase II
NCT06003270
InformationSeekingMesolimbicEngagementStudy2
NCT06257433
Food for Thought: Executive Functioning Around Eating Among Children
NCT06108128
Nurturing Needs Study: Parenting Food Motivated Children
NCT06111040
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
NCT05317832
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
NCT05499507
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888
Improving Participation in Universal School Meals (USM)
NCT06579079
Clavulanic Acid for the Treatment of Cocaine Use Disorder
NCT05562349
Wells and Enteric Disease Transmission
NCT04826991
ASSIST: Treatment for Childhood Apraxia of Speech
NCT03903120
Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935
Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3
NCT06182475
Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System
NCT07432555
Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.
NCT07505121
Enhancing Community Participation Through Peer-Delivered Decision Support
NCT06492434
InformationSeekingMesolimbicEngagementStudy1
NCT06257446
SAFE Workplace Intervention for People With IDD
NCT06112249
COVID-19 Self-testing IMPROVE
NCT06576167
Tolerance and Acute Effects of a New HFNT Nasal Cannula
NCT05182294
Association Between Types of Pain and Motor Activities Physical Activity
NCT05236933
Improving Quality of Life for Adults Living With HIV and Chronic Pain
NCT05055596
Diagnostic Accuracy of Handheld vs Traditional Ultrasound
NCT05196776
Virtual Reality for the Management of Pain and Anxiety for Outpatient Interventional Radiology Procedures
NCT06150963
The Effects of Caffeine on Human Spinal Motoneurons
NCT04891393
Parent Key Opinion Leaders to Increase Demand of Effective Treatments for Youth Anxiety
NCT04929262
Comparison of Time to Extubation Using Sugammadex or Neostigmine
NCT04606901
DCI COVID-19 Surveillance Project
NCT04780698
Improving Everyday Task Performance Through Repeated Practice in Virtual Reality.
NCT04315337
Game on Philly: Engaging Underserved Middle School Youth in Out-of- School Time Sports and Nutrition Education
NCT04975529
Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid
NCT04411914
Facilitating Engagement in Evidence-Based Treatment for Early Psychosis
NCT04532034
Wells and Enteric Disease Transmission Trial (WET - Trial)
NCT04258059
Feasibility of the SmartPrompt for Improving Everyday Function in Dementia
NCT04313582
Efficacy of an Internet-based Intervention for Dental Anxiety
NCT03680755
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
NCT03562416
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 17 |
| Phase 3 | 5 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the Temple University pipeline
21 recruiting of 163 indexed (13% open); 128 completed (79%).
Phase mix: 18 late (III/IV) vs 25 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Temple University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Temple University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Tufts University · 163 trials · 6% recruiting
- Wayne State University · 163 trials · 13% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
- Intermountain Health Care · 13% recruiting · 85 trials
Related
What to do with this Temple University page
163 registered trials is a research-attention snapshot, not an endorsement of Temple University or any single study.
- 21 of Temple University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Temple University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Temple University pipeline card: 163 registered trials from official public datasets.Report a data error.